Nano-X Imaging (NNOX) Total Non-Current Liabilities (2019 - 2026)
Nano-X Imaging's (NNOX) quarterly Total Non-Current Liabilities came in at $5.3 million in Q1 2026, down 20.72% YoY from $6.7 million in Q1 2025, and down 3.61% on a QoQ basis from $5.5 million in Q4 2025.
Nano-X Imaging (NNOX) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has 8 years of Total Non-Current Liabilities data on file, last reported at $5.3 million in Q1 2026.
- Quarterly Total Non-Current Liabilities fell 20.72% year-over-year to $5.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.3 million (down 20.72% YoY) and the FY2025 annual result came in at $5.5 million, down 19.77% from the prior year.
- Total Non-Current Liabilities slipped to $5.3 million in Q1 2026, from $5.5 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $19.2 billion in Q1 2022 to a low of $5.3 million in Q1 2026.
- A 5-year average of $2.8 billion and a median of $7.3 million in 2024 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 1931150.0% — and 2023, when it slumped 99.96%.
- Tracing NNOX's Total Non-Current Liabilities over 5 years: stood at $12.2 million in 2022, then slumped by 37.52% to $7.6 million in 2023, then retreated by 9.19% to $6.9 million in 2024, then decreased by 19.77% to $5.5 million in 2025, then slipped by 3.61% to $5.3 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $5.3 million (Q1 2026), $5.5 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Nano-X Imaging | 61,578.01 | -44.16 Mn | -2.59 Mn | 5.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.35 Mn |
| Dec 31, 2025 | 5.55 Mn |
| Sep 30, 2025 | 6.99 Mn |
| Jun 30, 2025 | 6.96 Mn |
| Mar 31, 2025 | 6.74 Mn |
| Dec 31, 2024 | 6.91 Mn |
| Sep 30, 2024 | 7.03 Mn |
| Jun 30, 2024 | 7.09 Mn |
| Mar 31, 2024 | 7.31 Mn |
| Dec 31, 2023 | 7.61 Mn |
| Sep 30, 2023 | 9.24 Mn |
| Jun 30, 2023 | 7.92 Mn |
| Mar 31, 2023 | 8.07 Mn |
| Dec 31, 2022 | 12.18 Mn |
| Sep 30, 2022 | 14.26 Bn |
| Jun 30, 2022 | 14.84 Bn |
| Mar 31, 2022 | 19.16 Bn |
| Dec 31, 2021 | 18.27 Mn |
| Sep 30, 2021 | 3.71 Mn |
| Jun 30, 2021 | 868,000.00 |